Study of Changing Trend in the Clinical Distribution of Candida Species in Various Clinical Samples at Tertiary Care Hospital, Ahmedabad, Gujarat
Keywords:
Candida, Species, infection, chrom agar, ClinicalAbstract
Introduction: The incidence of fungal infections has increased significantly, contributing to morbidity and mortality. Candida albicans remains the most common species causing human infections but recent epidemiological data reveal shift from C. albicans to non albicans Candida species. The aim of our study is to detect the clinical distribution of Candida species in a tertiary hospital.
Materials and Methods: Study of identification of Candida species was carried out at tertiary care hospital of Ahmedabad from 1st January 2016 to 30th June 2016.Total 102 candida isolates were identified from various clinical samples.. Identification of Candida species was done by standard techniques which include growth on Sabouraud dextrose agar and Chrom agar, Sabouraud dextrose broth, Germ tube test, slide culture on Cornmeal agar ,urease test and Carbohydrate utilization pattern by sugar assimilation test.
Results: Out of 102 Candida isolates collected 58% were from males and 42% from females. The distribution of the clinical samples was urine 51.96%, exudates 14.70%, respiratory 13.72% and blood 19.60%. In this study most frequently isolated Candida species was C. tropicalis 43 (42.15%) followed by C. albicans 37 (36.27%), C. guillermondii 14 (13.72%), and C. parapsilosis 4 (3.92%). C. kruzei 4 (3.92%). C.tropicalis was mainly isolated from urine samples.
Conclusions: The present study shows increased incidence of non albicans Candida as compared to Candida albicans.
References
Kett DH, Azoulay E, Echeverria PM, Vincent JL. Extended Prevalence of Infection in ICU Study (EPIC II) Group of In-vestigators. Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 2011;39:665‑70.
Akins RA. An update on antifungal targets and mechanisms of resistance in Candidaalbicans. Med Mycol 2005;43:285-318.
Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Ste-phens DS, Baughman WS, Reingold AL, Rothrock GA, Pfaller MA, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis. 1999;29:1164–1170.
Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med. 1988;148:2642–2645.
Knoke M, Schulz K, Bernhardt H. Dynamics of Candida iso-lations from humans from 1992-1995 in Greifswald, Germa-ny. Mycoses. 1997;40:105–110.
Shin JH, Lim WH, Shin DH, Suh SP, Ryang DW. Candida species isolated from clinical specimens and medical per-sonnel. Korean J Infect Dis. 1999;31:481–486.
Ainscough S, Kibbler CC. An evaluation of the cost-effectiveness of usingCHROMagar for yeast identifi cation in a routine microbiology laboratory. J MedMicrobiol 1998;47:623-8.
Arendrup MC, Sulim S, Holm A, Nielsen L, Nielsen SD, Knudsen JD, et al. Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia. J Clin Microbiol 2011;49:3300‑8.
Ostrosky‑Zeichner L, Shoham S, Vazquez J, Reboli A, Betts R, Barron M, et al. Msg‑01: A multicenter, randomized, dou-ble‑blind, placebo controlled trial of caspofungin (cas) prophylaxis vs placebo followed by pre‑emptive therapy for invasive candidiasis (ic) in high‑risk adults in the critical care setting. Preliminary results. SHEA Annual Scientific Meeting. Dallas, Texas, United States.
Hobson RP. The global epidemiology of invasive Candida infections-is the tide turning? J Hosp Infect 2003;55:159-68.
Chakraborti Aof the non-albicans Candida species and the distribution of the species wh, Gosh A, Batra R, Kaushal A, Roy P, Singh H. Antifungal susceptibhility patterns ich were isolated from candidaemia cases over a 5 year period. Indian J Med Res 1996; 104: 171-6.
Mokaddas EM, Al-Sweih NA, Khan ZU. The species distri-bution and the antifungal susceptibility of Candida blood-stream isolates in Kuwait: A 10 year study. J Med Microbiol 2007; 56: 255-96.
Saldhana et al. Species identification of Candida isolates in various clinical specimens with their antifungal susceptibil-ity .J Clin Di-agn Res. 2011 (suppl-1); 5(6): 1177-8
Jaya S, Harita V. Candida Species Isolated from Various Clinical Samples and Their Sus-ceptibility Patterns to Anti-fungals. J Med Microbiol Infec Dis.2013;1(1): 22-26
Sengupta P, Ohri VC. Study of yeast species isolated from clinical specimens. Medical Journal Armed Forces India 1999;55:319-21.
Agarwal S, Manchanda V, Verma N, Bhalla P. Yeast identifi cation in routine clinical microbiology laboratory and its clinical relevance. Indian J Med Microbiol 2011;29:172-7.
Dharwad S, Dominic SRM. Species identification of Candida isolates in various clinical specimens with their antifungal susceptibility patterns. J Antimicrob Chemother 2008;61:798-804.
Basu S, Harish C, Joshi, S Gupta N. Distribution of Candida species in different clinical sources in New Delhi, India, and proteinase and phospholipase activity of Candida albicans isolates. Rev Iberoam Micol 2003; 20:137-40.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
